Therefore, currently BChE inhibitors such as cymserine analogues and the dual inhibitor of both AChE and BChE such as rivastigmine are used therapeutically for treating Alzheimer's disease and other related dementias [43]. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.